Incidence rates of dilated cardiomyopathy in adult first-degree relatives versus matched controls

[1]  T. Biering-Sørensen,et al.  Rate of Heart Failure Following Atrial Fibrillation According to Presence of Family History of Dilated Cardiomyopathy or Heart Failure: A Nationwide Study , 2021, Journal of the American Heart Association.

[2]  N. Sattar,et al.  Higher Body Mass Index in Adolescence Predicts Cardiomyopathy Risk in Midlife , 2019, Circulation.

[3]  Parth N. Patel,et al.  Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy , 2019, Circulation.

[4]  Gonçalo Abecasis,et al.  Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation , 2018, JAMA.

[5]  Nicholette D. Palmer,et al.  Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries , 2018, PloS one.

[6]  D. O’Regan,et al.  Genetic Etiology for Alcohol-Induced Cardiac Toxicity , 2018, Journal of the American College of Cardiology.

[7]  R. Vasan,et al.  Epidemiology of cardiovascular disease in young individuals , 2018, Nature Reviews Cardiology.

[8]  A. Rosengren,et al.  High validity of cardiomyopathy diagnoses in western Sweden (1989–2009) , 2017, ESC heart failure.

[9]  L. Mestroni,et al.  Dilated Cardiomyopathy: Genetic Determinants and Mechanisms , 2017, Circulation research.

[10]  R. Vasan,et al.  Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012 , 2017, Circulation.

[11]  W. Stevenson,et al.  Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers. , 2016, Journal of the American College of Cardiology.

[12]  H. Bøtker,et al.  Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study , 2016, BMJ Open.

[13]  V. de Laurenzi,et al.  The prosurvival protein BAG3: a new participant in vascular homeostasis , 2016, Cell Death and Disease.

[14]  S. Heymans,et al.  Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. , 2016, European heart journal.

[15]  H. Bundgaard,et al.  Association Between Hypertensive Disorders of Pregnancy and Later Risk of Cardiomyopathy. , 2016, JAMA.

[16]  J. Seidman,et al.  Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. , 2016, The New England journal of medicine.

[17]  K. Stergiopoulos,et al.  Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. , 2016, The New England journal of medicine.

[18]  H. Bundgaard,et al.  Risk of Cardiomyopathy in Younger Persons With a Family History of Death from Cardiomyopathy: A Nationwide Family Study in a Cohort of 3.9 Million Persons , 2015, Circulation.

[19]  K. Swedberg,et al.  Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden , 2013, European heart journal.

[20]  David M Herrington,et al.  Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association. , 2013, Circulation.

[21]  L. Mestroni,et al.  Truncations of titin causing dilated cardiomyopathy. , 2012, The New England journal of medicine.

[22]  Timothy L Lash,et al.  The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients , 2011, BMC medical research methodology.

[23]  L. Fauchier,et al.  A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. , 2011, European heart journal.

[24]  J. Tolstrup,et al.  Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study , 2011, BMJ : British Medical Journal.

[25]  L. Mestroni,et al.  Prognostic impact of familial screening in dilated cardiomyopathy , 2010, European journal of heart failure.

[26]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[27]  L. Melton,et al.  Epidemiology of Idiopathic Dilated and Hypertrophic Cardiomyopathy , 2005 .

[28]  A. Matsumori,et al.  Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey , 2002, Heart.

[29]  G. Sinagra,et al.  Epidemiology of dilated cardiomyopathy , 1997 .

[30]  A. di Lenarda,et al.  Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group. , 1997, European heart journal.

[31]  S. Coughlin,et al.  Descriptive epidemiology of idiopathic dilated cardiomyopathy in Washington County, Maryland, 1975-1991. , 1993, Journal of clinical epidemiology.

[32]  L. Melton,et al.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.

[33]  K. Rasmussen,et al.  Cardiomyopathy in western Denmark. , 1984, British heart journal.

[34]  A. Torp.  Incidence of congestive cardiomyopathy. , 1978, Postgraduate medical journal.